Finzati - Logo
CRDL logo

Cardiol Therapeutics Inc.

CRDL • Drug Manufacturers - Specialty & Generic
$1.15
▲ +0.05 (+4.55%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$132.18M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 4.16Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:58 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.15
Change4.55%
Shares Out114.94M
Market Cap$132.18M
52W Range0.88 - 1.77
Beta0.51
P/E-3.17
P/S0.00
P/B5.67
P/FCF-18.15
EV/Sales0.00
EV/EBITDA-18.25

Investment DNA

How strong this company looks for long-term investors

40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 4.16Weak profitability

Analyst view

Analyst sentiment and price target

CRDL
Analyst sentiment
Based on 2 analyst votes · 2026-10-21
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$8.00
Mean
$8.00
Median
$8.00
High
$8.00

Company Overview

IPO: 1/15/2019
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 5.67
Debt / Equity i: 0.01
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 4.16
Quick Ratio: 4.16
Status: Good
🧾

No insider activity

No recent insider transactions available.